Oral Antibiotics for Severe Conjunctivitis in Adults
For severe bacterial conjunctivitis in adults, oral antibiotics are NOT routinely indicated—topical antibiotics are the standard of care for most cases. However, oral systemic antibiotics are specifically required for gonococcal and chlamydial conjunctivitis due to risk of serious complications 1.
When Oral Antibiotics ARE Indicated
Gonococcal Conjunctivitis
- First-line treatment: Ceftriaxone 1 g IM as a single dose 1
- PLUS concurrent treatment for chlamydia (since co-infection occurs in most cases):
- Azithromycin 1 g orally as a single dose, OR
- Doxycycline 100 mg orally twice daily for 7 days 1
Chlamydial Conjunctivitis
- Azithromycin 1 g orally as a single dose (preferred for convenience and compliance) 1
- Alternative options:
- Doxycycline 100 mg orally twice daily for 7 days
- Levofloxacin 500 mg orally once daily for 7 days 1
When Oral Antibiotics Are NOT Indicated
For typical bacterial conjunctivitis (caused by Staphylococcus aureus, Streptococcus pneumoniae, Haemophilus influenzae, Moraxella catarrhalis):
- Use topical antibiotics only (fluoroquinolones or azithromycin drops/ointment) 2, 3
- Most cases are self-limited, resolving in 1-2 weeks even without treatment 4, 5
- Topical antibiotics modestly improve clinical cure by 26% and speed recovery 4
- Oral cefixime has been studied but showed no advantage over topical therapy and did not prevent complications like acute otitis media 6
Critical Clinical Distinctions
Red flags requiring systemic antibiotics:
- Hyperacute presentation with copious purulent discharge (suggests gonococcus)
- Sexual history or concurrent STI symptoms
- Severe conjunctival inflammation with preauricular lymphadenopathy
- Contact lens wearer with severe infection (requires aggressive treatment for Pseudomonas)
- Neonatal conjunctivitis (requires systemic therapy)
Common pitfall: Prescribing oral antibiotics for routine bacterial conjunctivitis wastes resources, increases antibiotic resistance, and provides no benefit over topical therapy 6, 4. The exception is sexually transmitted infections where systemic treatment prevents serious sequelae including corneal perforation (gonorrhea) and systemic dissemination.
Practical Algorithm
Assess severity and risk factors:
- Hyperacute onset + copious purulent discharge + sexual risk factors → Suspect gonorrhea → Ceftriaxone 1 g IM + azithromycin 1 g PO
- Chronic/subacute with follicular reaction + sexual risk factors → Suspect chlamydia → Azithromycin 1 g PO single dose
- Mucopurulent discharge, matted lids, no sexual risk → Typical bacterial → Topical antibiotics only
For confirmed gonococcal or chlamydial infection: Always treat systemically and consider infectious disease consultation if cephalosporin allergy exists 1
For all other bacterial conjunctivitis: Topical therapy is sufficient; oral antibiotics add no clinical benefit 6, 4
Note: The 2024 Conjunctivitis Preferred Practice Pattern 1 emphasizes that systemic antibiotics are reserved exclusively for gonococcal and chlamydial infections in adults, reflecting CDC guidelines for sexually transmitted disease treatment.